Caribou Biosciences (CRBU) Revenue (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Caribou Biosciences | 232.46 Mn | 114.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.18% |
| Dec 31, 2025 | 79.30% |
| Sep 30, 2025 | -17.59% |
| Jun 30, 2025 | 13.34% |
| Mar 31, 2025 | 13.29% |
| Dec 31, 2024 | 2.62% |
| Sep 30, 2024 | -41.57% |
| Jun 30, 2024 | 42.61% |
| Mar 31, 2024 | -31.73% |
| Dec 31, 2023 | -84.96% |
| Sep 30, 2023 | 530.15% |
| Jun 30, 2023 | 7.22% |
| Mar 31, 2023 | -5.15% |
| Dec 31, 2022 | 11.78% |
| Sep 30, 2022 | -21.21% |
| Jun 30, 2022 | 57.36% |
| Mar 31, 2022 | 4.10% |
| Dec 31, 2021 | -35.66% |
| Sep 30, 2021 | 169.44% |
| Jun 30, 2021 | -6.94% |
| Mar 31, 2021 | 61.18% |
| Dec 31, 2020 | -17.86% |
| Sep 30, 2020 | -85.87% |
| Jun 30, 2020 | 398.41% |